1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Bruno Bockorny: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AGEN1423 and Botensilimab w/ or w/o Chemo in PDAC AGEN1423, Botensilimab, Gemcitabine - Advanced Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma | Phase 2 | Active not recruiting | Bruno Bockorny | 24 | 2024-08-08 | 2026-07-09 |
130-nm albumin-bound paclitaxel (1) · Albumin-Bound Paclitaxel (1) · Gemcitabine (1)
United States (1)